Poolbeg Pharma (LON:POLB) Trading 5.2% Higher – Here’s Why

Poolbeg Pharma PLC (LON:POLBGet Free Report) shares shot up 5.2% during mid-day trading on Wednesday . The company traded as high as GBX 8.10 ($0.11) and last traded at GBX 8.10 ($0.11). 475,472 shares were traded during trading, a decline of 73% from the average session volume of 1,772,456 shares. The stock had previously closed at GBX 7.70 ($0.10).

Poolbeg Pharma Price Performance

The stock has a market capitalization of £39 million, a P/E ratio of -810.00 and a beta of 2.11. The stock’s fifty day moving average price is GBX 9.74 and its 200 day moving average price is GBX 11.65.

Poolbeg Pharma Company Profile

(Get Free Report)

Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class broad spectrum RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis.

Further Reading

Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.